Boehringer Mannheim completes first U.S. installation of Clinical Laboratory Automation System - CLAS.SOUTH BEND South Bend, city (1990 pop. 105,511), seat of St. Joseph co., N Ind., on the great south bend of the St. Joseph River, in a farming and mint-growing region; inc. as a city 1865. , Ind.--(HealthWire)--Dec. 19, 1996-- Next Great Breakthrough in Laboratory Systems Leads to Cost Savings and Increased Laboratory Efficiency Boehringer Mannheim Corporation's (BMC (BMC Software, Inc., Houston, TX, www.bmc.com) A leading supplier of software that supports and improves the availability, performance, and recovery of applications in complex computing environments. ) Lab Diagnostics division recently completed the installation of its Clinical Laboratory Automation System(TM) (CLAS CLAS 1. Cholesterol-Lowering Atherosclerosis Study A study using colestipol and niacin in ♂ with previous CABG surgery 2. Circulating lupus anticoagulant syndrome. See Antiphospholipid antibody syndrome, Lupus anticoagulant. ) at the South Bend Medical Foundation, the largest laboratory in Indiana. This is the first U.S. installation of CLAS, which has been implemented in more than 70 laboratories worldwide. The technology for CLAS, the most comprehensive and only turn-key system in the industry, was thoroughly developed and customized for the Foundation in a year long process, and installed in just over 30 days. The Boehringer Mannheim/Hitachi CLAS system automates current and expected workflow within the diagnostic laboratory, including chemistry, hematology, coagulation coagulation (kōăg'y  lā`shən), the collecting into a mass of minute particles of a solid dispersed throughout a liquid (a sol), usually followed by the precipitation or , immunochemistry ImmunochemistryA discipline concerned both with the structure of antibody (immunoglobulin) molecules and with their ability to bind an apparently limitless number of diverse chemical structures (antigens); with the structure, organization, and rearrangement and urinalysis urinalysis (y  r'ənăl`ĭsĭs), clinical examination of urine for the purpose of medical diagnosis. testing. Laboratories automated with CLAS experience efficient, organized, safe and less costly procedures. Previous labor and time-intensive functions such as specimen tube sorting, centrifuging and decapping, sample aliquoting, barcode labeling, transportation to testing areas and loading into analyzers is completed effortlessly with CLAS. Laboratories also experience a decrease in biohazard bi·o·haz·ardn. 1. A biological agent, such as a virus or a condition that constitutes a threat to humans, especially in biological research or experimentation. 2. exposure to laboratory technicians. "Operating efficiencies will increase tremendously as a result of CLAS," said Dennis Lamb, vice president of central laboratory operations at the South Bend Medical Foundation. "We are committed to pioneering new standards to meet the health care needs of the community with continuous, uninterrupted service. CLAS technology will allow us to expand our testing capabilities, improve turnaround time (1) In batch processing, the time it takes to receive finished reports after submission of documents or files for processing. In an online environment, turnaround time is the same as response time. and consolidate workstations." CLAS technology is made possible by a long-term alliance with Hitachi, Ltd. For nearly 20 years, Hitachi and BMC have provided a steady stream of innovative clinical chemistry, immunochemistry and urinalysis systems. With agreements reaching well into the 21st century, both partners are committed to continuing to deliver automated, consolidated and integrated laboratory solutions to reduce healthcare costs. In addition, several other partners played key roles in this specific CLAS installation at the South Bend Medical Foundation: -- Cerner -- provided the laboratory information systems -- Data Innovations -- provided the systems interface -- Sysmex -- provided the automated hematology system "Our main goal in Boehringer Mannheim's partnership with the South Bend Medical Foundation is to provide the technology to enable the Foundation to better serve its customers -- to get results to the physician earlier," said George Fiedler, head, strategic business unit, laboratory automation at Boehringer Mannheim Lab Diagnostics. "By automating the Foundation's procedures, some tests not previously performed can be completed in the laboratory, resulting in greater capability and quicker turnaround time." Boehringer Mannheim Lab Diagnostics is based in Indianapolis, Indiana “Indianapolis” redirects here. For other uses, see Indianapolis (disambiguation). Indianapolis (IPA: [ˌɪndiəˈnæpəlɪs]) is the capital city of the U.S. and is a division of Boehringer Mannheim Group of Mannheim, Germany. The Boehringer Mannheim Group is a diversified international healthcare company with net sales Net Sales The amount a seller receives from the buyer after costs associated with the sale are deducted. Notes: This amount is calculated by subtracting the following items from gross sales: merchandise returned for credit, allowances for damaged or missing goods, freight of nearly $4 billion in 1995 and nearly 18,000 employees worldwide. In Diagnostics, Therapeutics and Biochemicals, Boehringer Mannheim Group's products, research, patient-focused health education and training programs are world leading. The Group is part of Corange Limited, which is privately-held and recorded sales of nearly $4 billion in 1995. EDITOR'S NOTE Editor's Note (foaled in 1993 in Kentucky) is an American thoroughbred Stallion racehorse. He was sired by 1992 U.S. Champion 2 YO Colt Forty Niner, who in turn was a son of Champion sire Mr. Prospector and out of the mare, Beware Of The Cat. Trained by D. : There is an "at" symbol after "Karen_McJunkin" and "jheld" in the E-mail addresses below. This symbol may not appear properly in some systems. CONTACT: Boehringer Mannheim Corp. -- Lab Diagnostics Karen McJunkin, 317/845-2000, ext. 7249 Karen_McJunkin@bmc.boehringer-mannheim.com or Edelman Healthcare Jenna Held, 312/240-2701 jheld@edelman.com |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion